Mike Raab is the founder of Ardelyx. Ardelyx has raised $61M in total funding. Latest round: IPO. Based in Irvine, California.
Mike Raab is the President and Chief Executive Officer of Ardelyx, a biotechnology company focused on developing small molecule therapeutics. He leads the company in advancing Tenapanor through FDA review for treating chronic kidney disease in dialysis patients and oversees Ardelyx's clinical strategy.
Full founder directory · Investor directory · Company funding database · Fundraising library